Physician profile
Eric C Bunting
NPI 1952302341
$8,775.58
in general payments reported to CMS, 2019-2025
29 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,220 · 2020: $867 · 2021: $1,179 · 2022: $806 · 2023: $454 · 2024: $854 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.63 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $5,595.94 | 2019-2022 | |
| Medtronic, INC. | $589.73 | 2021-2023 | Truclear |
| Inspire Medical Systems, INC. | $422.88 | 2023-2025 | Inspire |
| Aerin Medical INC. | $408.19 | 2019-2025 | |
| Glaxosmithkline, LLC. | $272.77 | 2022-2025 | Nucala |
| Stryker Corporation | $267.02 | 2019-2020 | |
| Integra Lifesciences Corporation | $188.23 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Hologic Sales and Service, LLC | $182.20 | 2023-2025 | Coolseal Generator, Myosure Tissue Removal Device, Omni Hysteroscope |
| Acclarent, INC | $134.63 | 2019-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Tract |
| Optinose US, INC. | $87.52 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $64.45 | 2025 | |
| Amgen INC. | $61.62 | 2025 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2024 | |
| Olympus America INC. | $49.92 | 2019-2023 | 4k Cable 8.5m |
| Ethicon US, LLC | $48.58 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $39.36 | 2019-2020 | |
| Smith+Nephew, INC. | $37.00 | 2019-2020 | |
| Greer Laboratories, INC. | $36.41 | 2025 | Oralair |
| Innovation Technologies INC | $32.26 | 2022-2023 | Irrisept |
| Neurent Medical Limited | $31.47 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Apria Healthcare LLC | $31.04 | 2021 | |
| Davol INC. | $24.45 | 2021 | |
| Avanos Medical | $21.98 | 2023 | Pnb and Accessories |
| Genzyme Corporation | $20.08 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Xhance |
| Novartis Pharmaceuticals Corporation | $15.72 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.01 | 2024 | Dupixent |
| Arbor Pharmaceuticals, INC. | $14.42 | 2020 | |
| Alk-Abello, INC | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bunting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.